Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis.
Journal: Paediatric respiratory reviews
Published: March 04, 2026
Evaluation of Family History of Diabetes and the Development of Cystic Fibrosis-Related Diabetes in a Clinical Cystic Fibrosis Cohort.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 18, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study.
Journal: Annals of the American Thoracic Society
Published: September 08, 2025
An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis Exacerbations.
Journal: Open forum infectious diseases
Published: August 12, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study.
Journal: Annals of the American Thoracic Society
Published: March 04, 2025
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
Journal: Annals of the American Thoracic Society
Published: July 23, 2024
Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis.
Journal: Respiration; international review of thoracic diseases
Published: June 24, 2024
Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 08, 2024
A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.
Journal: Pediatric pulmonology
Published: December 06, 2023
Predicting weight gain in patients with cystic fibrosis on triple combination modulator.
Journal: Pediatric pulmonology
Published: September 20, 2023
Mutations in the C-terminal region of the bacteriophage exclusion protein PglX can selectively inactivate restriction in Salmonella.
Journal: Journal of bacteriology
Published: September 20, 2023
Last Updated: 09/26/2026